Q3 2023 Eris Lifesciences Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to Eris Lifesciences Limited Q3 FY '23 Earnings Conference Call. We have with us on the call today, Mr. Amit Bakshi, Chairman and Managing Director; and Mr. V. Krishnakumar, Executive Director and Chief Operating Officer.
(Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. V. Krishnakumar, Executive Director and Chief Operating Officer. Thank you, and over to you, sir.
Thank you. I'm Krishnakumar and I wish you all a very Happy New Year. Welcome to our earnings call for the third quarter of financial year '23. We've just announced the acquisition of 9 dermatology brands from Glenmark. This deal is in line with our stated intent of building a strong dermatology franchise. We started this process with the acquisition of Oaknet in May 2002 (sic) [2022].
The acquisition of the Glenmark brands will help consolidate our position further, especially in the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
